BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 3
  • This Article
Peer-Review Report of This Article
Journal Information of This Article
Publication Name
Artificial Intelligence in Gastroenterology
ISSN
2644-3236
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Nov 8, 2026; 7(3): 124329
Published online Nov 8, 2026. doi: 10.35712/aig.124329
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Multimodal artificial intelligence pathway for metabolic dysfunction-associated steatotic liver disease diagnosis and prognosis. AI: Artificial intelligence; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CT: Computed tomography; EHR: Electronic health record; MASLD: Metabolic dysfunction-associated steatotic liver disease; MRI-PDFF: Magnetic resonance imaging proton-density fat fraction.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Artificial intelligence-supported therapeutic pathway in metabolic dysfunction-associated steatotic liver disease. EHR: Electronic health record.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.